Organization: Health Canada
Year: 2024
Month: June
Request Number: A-2023-001219
Request Summary: In respect of the second, newest Abbreviated New Drug Submission (ANDS) for liraglutide provide copies of all correspondence or other records relating to any pre-submission or pre-application meeting(s) requested by the sponsor.
Disposition: Disclosed in part
Number of pages: 117